Clinical Trials Insight: 700033750
Phase of Trial: Phase I
Latest Information Update: 15 Jan 2010
At a glance
- Drugs EVT 101 (Primary)
- Indications Alzheimer's disease; Depression; Neuropathic pain; Parkinson's disease
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Evotec
- 03 Jul 2008 Status changed from in progress to completed.
- 03 Jul 2008 Top-line results reported in an Evotec media release.
- 20 May 2008 New trial record.